Kymera Therapeutics On Track for Record High Closing -- Data Talk
Dow Jones2026/08/17 15:20Kymera Therapeutics, Inc. (KYMR) is currently at $120.86, up $3.47 or 2.96%
--Would be new all-time closing high (Based on available data back to Aug. 21, 2020)
--On pace for largest percent increase since Aug. 12, 2026, when it rose 4.02%
--Currently up 10 consecutive days; up 20.49% over this period
--Longest winning streak since Jan. 3, 2022, when it rose for 11 straight trading days
--Best 10 day stretch since the 10 days ending July 6, 2026, when it rose 26.9%
--Up 16.89% month-to-date
--Up 55.33% year-to-date
--Up 177.07% from 52 weeks ago (Aug. 18, 2025), when it closed at $43.62
--Would be a new 52-week closing high
--Up 197.03% from its 52-week closing low of $40.69 on Sept. 2, 2025
--Traded as high as $120.86; highest intraday level since July 7, 2026, when it hit $120.90
--Up 2.96% at today's intraday high
All data as of 11:12:04 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 17, 2026 11:20 ET (15:20 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-IIFL Finance rallies to a two-month high, boosted by Blackstone deal
The “outlier” in the AI capital expenditure frenzy: Apple (AAPL.US) keeps spending flat, accounting for less than 5% of sales
Apple continues to stand out among major tech peers, largely avoiding the aggressive wave of capital expenditure associated with artificial intelligence (AI) infrastructure.

Youth Employment Declines for 48 Consecutive Months: Behind the Semiconductor Boom, Young South Koreans Are Being Left Behind by the Times
In South Korea, the unemployment rate in October fell to a three-year low of 2.5%. However, the number of employed people decreased by 50,000, youth employment has declined for 48 consecutive months, and domestic demand remains weak.

